Company Overview and News


Add MYX
to your dashboard

Headline News

Last week for tax-loss selling before the July bounce

2017-06-18 theage.com.au
Tax loss selling has hammered some shares this season, but the strategy is gearing up to have one last wash through the ASX this week before the July pickup.

Last week for tax-loss selling before the July bounce

2017-06-18 smh.com.au
Tax loss selling has hammered some shares this season, but the strategy is gearing up to have one last wash through the ASX this week before the July pickup.

Twenty U.S. states join generic drug price-fixing lawsuit

2017-03-01 reuters
WASHINGTON, March 1 California, Illinois and 18 more states have joined a lawsuit filed last year alleging that six companies, including Mylan NV and Teva Pharmaceutical Industries Ltd, conspired to push up prices of two generic drugs, the Connecticut attorney general's office said on Wednesday.

FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Impax Laboratories Inc. (IPXL) and Lead Plaintiff Deadline: January 9, 2017

2017-01-09 accesswire
NEW YORK, NY / ACCESSWIRE / January 9, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Impax Laboratories Inc. ("Impax" or the "Company") (NASDAQ: IPXL) and certain of its officers. This class action is on behalf of a class consisting of all persons who purchased Impax between February 25, 2014 and November 3, 2016, both dates inclusive (the "Class Period").

DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lannett Company Inc. (LCI) and Lead Plaintiff Deadline: January 17, 2017

2017-01-05 accesswire
NEW YORK, NY / ACCESSWIRE / January 5, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lannett Company Inc. ("Lannett" or the "Company") (NYSE: LCI) and certain of its officers, and is on behalf of shareholders who purchased or otherwise acquired Lannett securities between September 12, 2013 and November 3, 2016, both dates inclusive (the "Class Period").

DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Impax Laboratories Inc. (IPXL) and Lead Plaintiff Deadline: January 9, 2017

2017-01-04 accesswire
NEW YORK, NY / ACCESSWIRE / January 4, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Impax Laboratories Inc. ("Impax" or the "Company") (NASDAQ: IPXL) and certain of its officers. This class action is on behalf of a class consisting of all persons who purchased Impax between February 25, 2014 and November 3, 2016, both dates inclusive (the "Class Period").

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lannett Company Inc. (LCI) and Lead Plaintiff Deadline: January 17, 2017

2016-12-29 accesswire
NEW YORK, NY / ACCESSWIRE / December 29, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lannett Company Inc. ("Lannett" or the "Company") (NYSE: LCI) and certain of its officers, and is on behalf of shareholders who purchased or otherwise acquired Lannett securities between September 12, 2013 and November 3, 2016, both dates inclusive (the "Class Period").

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Endo International PLC (ENDP) and Lead Plaintiff Deadline: January 6, 2017

2016-12-28 accesswire
NEW YORK, NY / ACCESSWIRE / December 28, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Endo International PLC ("Endo" or the "Company") (NASDAQ: ENDP) and certain of its officers. This class action is on behalf of a class consisting of all persons who purchased Endo between September 28, 2015 and November 2, 2016, both dates inclusive (the "Class Period").

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Impax Laboratories Inc. (IPXL) and Lead Plaintiff Deadline - January 9, 2017

2016-12-28 accesswire
NEW YORK, NY / ACCESSWIRE / December 28, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Impax Laboratories Inc. ("Impax" or the "Company") (NASDAQ: IPXL) and certain of its officers. This class action is on behalf of a class consisting of all persons who purchased Impax between February 25, 2014 and November 3, 2016, both dates inclusive (the "Class Period").

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lannett Company Inc. (LCI) and Lead Plaintiff Deadline: January 17, 2017

2016-12-22 accesswire
NEW YORK, NY / ACCESSWIRE / December 22, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lannett Company Inc. ("Lannett" or the "Company") (NYSE: LCI) and certain of its officers, and is on behalf of shareholders who purchased or otherwise acquired Lannett securities between September 12, 2013 and November 3, 2016, both dates inclusive (the "Class Period").

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Endo International PLC (ENDP) and Lead Plaintiff Deadline: January 6, 2017

2016-12-20 accesswire
NEW YORK, NY / ACCESSWIRE / December 20, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Endo International PLC ("Endo" or the "Company") (NASDAQ: ENDP) and certain of its officers. This class action is on behalf of a class consisting of all persons who purchased Endo between September 28, 2015 and November 2, 2016, both dates inclusive (the "Class Period").

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Impax Laboratories Inc. (IPXL) and Lead Plaintiff Deadline - January 9, 2017

2016-12-20 accesswire
NEW YORK, NY / ACCESSWIRE / December 20, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Impax Laboratories Inc. ("Impax" or the "Company") (NASDAQ: IPXL) and certain of its officers. This class action is on behalf of a class consisting of all persons who purchased Impax between February 25, 2014 and November 3, 2016, both dates inclusive (the "Class Period").

US lawmakers press Heritage Pharma on high prices for antibiotic

2016-12-16 channelnewsasia
WASHINGTON: Two U.S. lawmakers are questioning whether Heritage Pharmaceuticals misled them in response to a 2014 congressional inquiry about the rising price a common antibiotic, after 20 U.S. states this week accused the company of price fixing.

Mylan, Teva, Mayne Sued By 20 States Over Drug Price Fixing

2016-12-16 fortune
Shares in Mayne Pharma Group maynf plunged as much as 24% on Friday after several U.S. states filed a lawsuit alleging the Australian pharmaceutical firm had engaged in a conspiracy with others to fix prices on two generic drugs.

UPDATE 1-Australia's Mayne Pharma Group shares tumble on U.S. lawsuit

2016-12-16 reuters
SYDNEY Dec 16 Shares in Australian pharmaceutical company Mayne Pharma Group Ltd fell more than 16 percent on Friday after 20 U.S states filed a lawsuit against it alleging it engaged in a conspiracy with others to fix prices on two generic drugs.